Replies to post #48649 on Elite Pharmaceuticals Inc (ELTP)

[Drugdoctor]

LOL, do you think 3 drug launches will be enough to secure NET PROFITABLE operations by the end of this year, with the growth of the other products and the new products combined?

[Drugdoctor]

What do you think the abuse resistant drug about to enter HUMAN trials will have for active ingredients?

[Couch]

Compensation is highly relevant. It is factual, not fantasy about the future.

We have come to this very same conclusion and this has lead us to continue to buy shares here at a deep discount.

It’s interesting to me that someone who worked on Wall Street for 25 years and disparity in valuation between companies like Elite and other companies involved in development of abuse-resistant products like Pain Therapeutics, Acura, what it says to me is that, the investment community doesn’t really believe us yet, but these products are going to be real. Well, there is lot of people in this company including myself and Chris and Carter, and our Chief Scientific Officer who have been paid a significant amount of stock because we do believe that. And that market has developed in a way enormously to our advantage, and we think we have an officious technology that is in a lot of ways superior to approaches that other companies are taking.

Any Questions??
Nope

[Jimmy Joe]

Compensation is pointless unless someone is embezzling money somehow or cooking ones compensation. Its pretty much a moot point. What matters is the company
and how all things are coming into place in regard to execution. Just my opinion.